Business
Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the appointment of Jonathan M. Vigdorchik, M.D., as Chief Science, Technology and Medical Affairs Officer, effective April 14.
About this update from Zimmer Biomet Holdings, Inc.
[{"type":"text","content":"Experienced orthopedic surgeon from the Hospital for Special Surgery, innovator and former Chief Medical Technology Advisor joins company in an elevated capacity","length":161,"tagName":"p","attribs":{}},{"type":"text","content":"WARSAW, Ind., April 7, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the appointment of Jonathan M. Vigdorchik, M.D., as Chief Science, Technology and Medical Affairs Officer, effective April 14.","length":277,"tagName":"p"},{"type":"image","alt":"Dr. Jonathan M. Vigdorchik, Chief Science, Technology and Medical Affairs Officer, Zimmer Biomet","displaySize":"","headline":null,"caption":"Dr. Jonathan M. Vigdorchik, Chief Science, Technology and Medical Affairs Officer, Zimmer Biomet","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":395,"url":"https://media.zenfs.com/en/prnewswire.com/944176fe511b06d045b511e3c5a7b74e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/kRMKKgAenjdnD0VPYDG5xw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTY5Ng--/https://media.zenfs.com/en/prnewswire.com/944176fe511b06d045b511e3c5a7b74e","width":400,"height":395}},"href":"https://mma.prnewswire.com/media/2950758/Dr_Jonathan_M_Vigdorchik___Zimmer_Biomet.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"In this role, Dr. Vigdorchik will oversee the strategy, delivery, and management of the company's global end-to-end technology portfolio, including AI, robotics, smart implants and data. He will also oversee Zimmer Biomet's Medical Education strategy and Global Advisory Board, helping further strengthen Zimmer Biomet's clinical engagement, innovation roadmap and external scientific leadership. Dr. Vigdorchik will report to Ivan Tornos, Chairman, President and Chief Executive Officer.","length":505,"tagName":"p"},{"type":"text","content":""Dr. Vigdorchik is a world-class orthopedic surgeon, and he brings exactly the kind of bold, future-focused leadership we need as we continue to shape the next era of musculoskeletal care," said Tornos. "He understands how to translate clinical insight into meaningful innovation, and his leadership will help us move faster, think bigger and continue advancing our broad suite of robotic and enabling technologies. I'm confident he will...